Most Recent

image: Disputes Over Text-Mining

Disputes Over Text-Mining

By | March 21, 2013

Computer programs that trawl research papers can reveal important large-scale patterns and facilitate further research, but publishers are wary.

2 Comments

image: Anthrax Vax Test OK for Kids

Anthrax Vax Test OK for Kids

By | March 19, 2013

A presidential bioethics commission lays out the framework for testing the anthrax vaccine in children.

0 Comments

image: Opinion: Genomics in the Clinic

Opinion: Genomics in the Clinic

By | March 18, 2013

Next-generation sequencing diagnostics are already being used, and patients are ready.

0 Comments

image: Week in Review

Week in Review

By | March 15, 2013

Disgruntled Nobel loser sues; brain trauma researchers search for biomarker of a chronic condition; receptor for novel coronavirus found; the rise of transcriptomics; and ethical oversight of participant-led research

0 Comments

image: Novel Virus Entry Portal Found

Novel Virus Entry Portal Found

By | March 13, 2013

Researchers identify the target protein of a recently discovered human coronavirus, shedding light on infection and possible interspecies spread.

1 Comment

image: Opinion:  Unconventional Standards

Opinion: Unconventional Standards

By | March 13, 2013

Tailoring ethical oversight to participant-led research

2 Comments

image: Antibody-Dependent Enhanced (ADE) Immunity

Antibody-Dependent Enhanced (ADE) Immunity

By | March 2, 2013

The method to the dengue virus's maddening infectiousness.

0 Comments

image: Networking Medicine

Networking Medicine

By | March 2, 2013

Although fully organized patient-run trials are still few and far between, patients are taking a more active role in clinical research.

0 Comments

image: Bedeviled by Dengue

Bedeviled by Dengue

By | March 1, 2013

The global spread of dengue virus has immunologists and public-health experts debating the best way to curb infection.

5 Comments

image: Do-It-Yourself Medicine

Do-It-Yourself Medicine

By | March 1, 2013

Patients are sidestepping clinical research and using themselves as guinea pigs to test new treatments for fatal diseases. Will they hurt themselves, or science?

9 Comments

Popular Now

  1. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  2. How Plants Evolved Different Ways to Make Caffeine
  3. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  4. ESP on Trial
    Foundations ESP on Trial

    In the 1930s, parapsychologist Joseph Banks Rhine aimed to use scientific methods to confirm the existence of extrasensory perception, but faced criticisms of dubious analyses and irreproducible results.

RayBiotech